ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0475463 | Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. | Neutralizing antibody|antibody neutralizing|Antibody, Neutralizing|Neutralizing Antibody|Neutralising antibody|Neutralizing Antibodies|neutralizing antibody|Neutralizing antibody (substance)|Antibodies, Neutralizing | Antibodies, Neutralizing |
C0008905 | The main structural coat protein of COATED VESICLES which play a key role in the intracellular transport between membranous organelles. Each molecule of clathrin consists of three light chains (CLATHRIN LIGHT CHAINS) and three heavy chains (CLATHRIN HEAVY CHAINS) that form a structure called a triskelion. Clathrin also interacts with cytoskeletal proteins. | clathrin|Clathrin | Clathrin |
C1300203 | null | homo|Homo|homos|Genus Homo|Genus Homo (organism)|humans|Hominoid | Genus Homo |
C0598435 | Covalent attachment of PALMITIC ACIDS to other compounds and PROTEINS. | palmitoylation | Palmitoylation |
C0000928 | Unanticipated events associated with AIRCRAFT. | Airplane accident|Airplane accident (event)|Aeroplane accident|Aircraft accident|Aircraft accident (event)|Aviation Accident|Aircraft accidents|Accidents, Aviation|Airplane accidents|aircraft accident|aviation accident|Aeroplane accidents|airplane accident|Aviation Accidents|Accident, Aviation | Aircraft accidents |
C0052709 | null | avilamycin | avilamycin |
C0022985 | null | Laminin M | Laminin M |
C0598091 | null | null | stable cell line |
C0031617 | A complex mixture of PHOSPHOLIPIDS; GLYCOLIPIDS; and TRIGLYCERIDES; with substantial amounts of PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; and PHOSPHATIDYLINOSITOLS, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the CELL MEMBRANE and commercially extracted from SOYBEANS and EGG YOLK. The emulsifying and surfactant properties are useful in FOOD ADDITIVES and for forming organogels (GELS). | Lecithin-containing product|Phosphatidyl choline|Lecithin|LECITHIN|Product containing lecithin (medicinal product)|Phospholipid with Choline|lecithins|Lecithins|lecithin | lecithin |
C0016617 | Organizations established by endowments with provision for future maintenance. | foundations|Foundation|Foundations|foundation [organization]|foundation | Foundations |
C0061202 | An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE. | GENISTEIN|5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|Prunetol|prunetol|Genestein|4',5,7-trihydroxyisoflavone|genisterin|4',5, 7-Trihydroxyisoflavone|genisteol|Genisterin|genestein|Genistein|genistein|5,7,4'-trihydroxyisoflavone|sophoricol|5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|Genisteol|4',5,7-Trihydroxyisoflavone | genistein |
C1289792 | null | Implant made of silastic material, device|Implant made of silastic material, device (physical object)|silastic implant | Silastic implant |
C1449575 | The simultaneous analysis, on a microchip, of multiple samples or targets arranged in an array format. | microarray technology|Microarray-Based Analysis|Gene Expression Profiling|Microarray Technology|Microarray Analysis|gene expression profile|microarray analysis|Analysis, Microarray | Microarray Analysis |
C1429446 | null | null | ProU protein, Bacteria |
C1429446 | null | null | ProU protein, Bacteria |
C1519346 | The process by which normal skin cells are transformed into cancer cells. | null | Skin Carcinogenesis |
C0105770 | A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS. | beta-Catenin|beta Catenin|Catenin, beta|beta catenin|beta-catenin | beta catenin |
C0137209 | A multi-functional catenin that is highly homologous to BETA CATENIN. Gamma catenin binds CADHERINS and helps link their cytoplasmic tails to ACTIN in the CYTOSKELETON via ALPHA CATENIN. It is also found in DESMOSOMES where it mediates the link between DESMOSOMAL CADHERINS and DESMOPLAKIN. | plakoglobin|Desmoplakin III|Junctional Plakoglobin|Catenin, gamma|Plakoglobin, Junctional|Plakoglobin|gamma catenin|gamma Catenin|gamma-Catenin|Plakoglobin, Junction|Junction Plakoglobin | plakoglobin |
C0137209 | A multi-functional catenin that is highly homologous to BETA CATENIN. Gamma catenin binds CADHERINS and helps link their cytoplasmic tails to ACTIN in the CYTOSKELETON via ALPHA CATENIN. It is also found in DESMOSOMES where it mediates the link between DESMOSOMAL CADHERINS and DESMOPLAKIN. | plakoglobin|Desmoplakin III|Junctional Plakoglobin|Catenin, gamma|Plakoglobin, Junctional|Plakoglobin|gamma catenin|gamma Catenin|gamma-Catenin|Plakoglobin, Junction|Junction Plakoglobin | plakoglobin |
C0025723 | Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) | methylation|Methylations|Methylation | Methylation |
C0056912 | A dinucleotide consisting of cytosine followed by guanine. | cytosine-guanine dinucleotide|CpG|CG-dinucleotide|CpG dinucleotide|CpG Dinucleotide|cytidine monophosphate guanosine|3'-5'-CpG | cytidylyl-3'-5'-guanosine |
C0006007 | Inorganic or organic salts and esters of boric acid. | borates|Borate|borated|Borate salt|Borates|borate|Borate (substance) | Borates |
C0006007 | Inorganic or organic salts and esters of boric acid. | borates|Borate|borated|Borate salt|Borates|borate|Borate (substance) | Borates |
C0540654 | An APOPTOSIS-regulating protein that is structurally related to CASPASE 8 and competes with CASPASE 8 for binding to FAS ASSOCIATED DEATH DOMAIN PROTEIN. Two forms of CASP8 and FADD-like apoptosis regulating protein exist, a long form containing a caspase-like enzymatically inactive domain and a short form which lacks the caspase-like domain. | FLICE-Inhibitory Protein|FLICE Inhibitory Protein|CASP8 and FADD-Like Apoptosis Regulating Protein|Casper Protein|FLIP (Cellular)|CASP8 and FADD Like Apoptosis Regulating Protein | CASP8 and FADD-Like Apoptosis Regulating Protein |
C0246694 | null | MG132|MG-132|MG 132|Proteasome Inhibitor MG-132 | MG 132 |
C0105770 | A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS. | beta-Catenin|beta Catenin|Catenin, beta|beta catenin|beta-catenin | beta catenin |
C0171955 | null | laminin B1k|laminin 5|laminin-5|nicein|laminin 332|kalinin|epiligrin | laminin-5 |
C1512086 | null | Duct Epithelium | Ductal Epithelium |
C1292533 | A piece of tissue removed from an organism for examination, analysis, or propagation. | Tissue Sample|Tissue specimen (specimen) | Tissue specimen |
C0586362 | null | Pancreatic duct dysplasia (disorder) | Pancreatic duct dysplasia |
C1527078 | A recombinant form of the endogenous polypeptide hormone that exerts immunomodulatory effects primarily on mononuclear cells. Prothymosin alpha stimulates the production of various cytokines including granulocyte/macrophage colony stimulating factor (GM-CSF) alpha, gamma interferon (IFN) and interleukins such as IL-2. This agent may also increase some tumor antigens expression, thus inducing better T lymphocyte responses to tumor cells. Combined with chemotherapy, prothymosin alpha may exhibit significant anti-tumor effects. This agent also helps to regenerate lymph node and bone marrow cells after treatment with certain toxic chemotherapeutics. (NCI04) | Prothymosin Alpha|Recombinant Prothymosin Alpha | Recombinant Prothymosin Alpha |
C1527078 | A recombinant form of the endogenous polypeptide hormone that exerts immunomodulatory effects primarily on mononuclear cells. Prothymosin alpha stimulates the production of various cytokines including granulocyte/macrophage colony stimulating factor (GM-CSF) alpha, gamma interferon (IFN) and interleukins such as IL-2. This agent may also increase some tumor antigens expression, thus inducing better T lymphocyte responses to tumor cells. Combined with chemotherapy, prothymosin alpha may exhibit significant anti-tumor effects. This agent also helps to regenerate lymph node and bone marrow cells after treatment with certain toxic chemotherapeutics. (NCI04) | Prothymosin Alpha|Recombinant Prothymosin Alpha | Recombinant Prothymosin Alpha |
C0746574 | null | methylated | methylate |
C1176475 | Malignant neoplasms involving the ductal systems of any of a number of organs, such as the MAMMARY GLANDS, the PANCREAS, the PROSTATE, or the LACRIMAL GLAND. | ductal carcinomas|Duct carcinoma, NOS|adenocarcinoma duct|Carcinoma, Ductal|carcinoma infiltrating duct|carcinoma ducts|duct adenocarcinoma|carcinomas ductal|Duct cell carcinoma|ductal carcinoma|duct carcinoma|Ductal Carcinoma|Carcinomas, Ductal|Duct carcinoma|Ductal carcinoma|infiltrating duct carcinoma|Ductal Carcinomas|Duct adenocarcinoma, NOS|carcinoma ducted|carcinoma ductal|duct cell carcinoma|Duct adenocarcinoma | Ductal Carcinoma |
C1514559 | In biology, to make too many copies of a protein or other substance. Overexpression of certain proteins or other substances may play a role in cancer development. | Overexpression|overexpress | Protein Overexpression |
C1151757 | Catalysis of the reaction: succinate + acceptor = fumarate + reduced acceptor. [EC:1.3.99.1, GOC:kd] | fumarate reductase activity|succinodehydrogenase activity|succinic acid dehydrogenase activity|succinate dehydrogenase activity|succinate:acceptor oxidoreductase activity|succinyl dehydrogenase activity|succinate:(acceptor) oxidoreductase activity|succinate oxidoreductase activity|fumaric hydrogenase activity|fumarate dehydrogenase activity | fumarate reductase activity |
C0034667 | Regularly spaced gaps in the myelin sheaths of peripheral axons. Ranvier's nodes allow saltatory conduction, that is, jumping of impulses from node to node, which is faster and more energetically favorable than continuous conduction. | node of ranvier|Node of Ranvier|Ranviers Nodes|Ranvier Nodes|node of Ranvier|nodes of ranvier|Ranvier node|Nodes, Ranvier's|Ranvier's node|Nodes of Ranvier|Ranvier's node (cell structure) | Ranvier's Nodes |
C0334220 | The reforming of the MYELIN SHEATH around AXONS following loss due to injury or DEMYELINATING DISEASES. | Remyelination (morphologic abnormality)|Remyelinations|Remyelination|remyelination | Remyelination |
C0746922 | Any bulge or swelling of an anatomical structure or part. | nodes|noded|node|Node | Anatomic Node |
C0524914 | Cell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif. | Chemokine Receptor|chemokine receptor|chemokine receptors|Receptors, Chemokine|Chemokine Receptors | chemokine receptor |
C0018220 | Region of CENTRAL NERVOUS SYSTEM that appears darker in color than the other type, WHITE MATTER. It is composed of neuronal CELL BODIES; NEUROPIL; GLIAL CELLS and CAPILLARIES but few MYELINATED NERVE FIBERS. | gray matter|Gray Matters|Grey substance|Gray Matter|substantia grisea|Matter, Grey|Grey Matter|Matter, Gray|Grey Matters|Gray matter of neuraxis|Matters, Gray|Grey matter|Matters, Grey|Substantia grisea|Gray matter|Gray matter, NOS | Gray Matter |
C0030560 | Upper central part of the cerebral hemisphere. It is located posterior to central sulcus, anterior to the OCCIPITAL LOBE, and superior to the TEMPORAL LOBES. | Lobe, Parietal|parietal cortex|PARIETAL LOBE|Regio parietalis|Region, Parietal|Parietal region|lobus parietalis|Parietal lobe|PARIETAL LOBES|Parietal Regions|parietal lobe|Parietal lobe, NOS|Regions, Parietal|Lobes, Parietal|Parietal lobe structure|Cortex, Parietal|Lobus parietalis|parietal region|Parietal Cortices|Parietal Region|Parietal Cortex|Cortices, Parietal|Parietal Lobe|Parietal lobe structure (body structure)|Parietal Lobe of the Brain|Parietal cortex|Parietal Lobes|lobe parietal|parietal lobes|Parietal lobes | Parietal Lobe |
C0042333 | Genotypic differences observed among individuals in a population. | Variation, Genetic|Diversity, Genetic|Sequence Variation|V subscript G|Sequence Variant|genetic variation|Genetic variation (finding)|genetic variations|Variations, Genetic|Genetic Variations|genetic diversity|Genetic variation|genetic variance|Genetic Diversity|Diversities, Genetic|Genetic Diversities|Genetic Variation | Variation (Genetics) |
C0037771 | Mild or moderate loss of motor function accompanied by spasticity in the lower extremities. This condition is a manifestation of CENTRAL NERVOUS SYSTEM DISEASES that cause injury to the motor cortex or descending motor pathways. | Parapareses, Spastic|Spastic Lower Extremity Weakness|spastic paraparesis|spastic parapareses|Spastic Paraparesis|Lower Extremity Weakness, Spastic|Spastic Parapareses|Spastic paraparesis (finding)|Spastic paraparesis | Paraparesis, Spastic |
C1564139 | A protein with an amino acid sequence that differs from the wildtype, canonical sequence. | Proteins, Mutant|Protein Variant|Protein, Mutant|Mutant Protein | Mutant Proteins |
C0004745 | A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS. | Barbiturate|Barbiturates|Barbiturate, NOS|Barbiturate-containing product|Barbiturate (substance)|barbiturate|Product containing barbiturate (product)|BARBITURATES|barbiturates | Barbiturates |
C1414745 | null | FRA20A|fragile site, folic acid type, rare, fra(20)(p11.23)|FRA20A gene | FRA20A gene |
C1414745 | null | FRA20A|fragile site, folic acid type, rare, fra(20)(p11.23)|FRA20A gene | FRA20A gene |
C0162735 | A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. | Point Mutation|point mutation|Point mutation (finding)|Point mutation|point mutations|Mutation, Point|Point Mutations|Mutations, Point | Point Mutation |
C0010412 | The application of cold to appropriate painful areas to reduce inflammation immediately after an injury. | cold therapy|Therapy, Cold|Therapies, Cold|Application of cold, therapeutic|Therapy by cooling|cold therapies|Cold therapy (regime/therapy)|Cold, application, therapeutic|Cold therapy|Cold Therapy|Therapeutic application of cold|Cooling therapy|cold temperature therapy|Cold Therapies|Therapeutic Cold | Cold Therapy |
C1512886 | Sequences within MESSENGER RNA that enable PROTEIN TRANSLATION INITIATION independent of 5' CAPPED RNA. | Internal Ribosome Entry Site|Ribosome Entry Site|IRES | Internal Ribosome Entry Sites |
C0045212 | A synthetic pyrimidine analogue with activity against hepatitis B virus (HBV). Intracellularly, clevudine is phosphorylated to its active metabolites, clevudine monophosphate and triphosphate. The triphosphate metabolite competes with thymidine for incorporation into viral DNA, thereby causing DNA chain termination and inhibiting the function of HBV DNA polymerase (reverse transcriptase). Clevudine has a long half-life and shows significant reduction of covalently closed circular DNA (cccDNA), therefore the patient is less likely to have a relapse after treatment is discontinued. | CLEVUDINE|FMAU|2'-fluoro-5-methylarabinosyluracil|1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)thymine|1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione|2'-fluoro-5-methyl-1-beta-arabinosyluracil|l-fmau|2'-fluoro-1-beta-arabinofuranosyl-5-methyluracil|1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyl-|2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil|2'-Fluoro-5-methyl-beta-L-arabinofuranosyluracil|1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)thymine; 2,4(1H,3H)-pyrimidinedione|2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyl-|clevudine|Clevudine|1-(2-fluoro-5-methyl-beta,L-arabinofuranosyl)uracil|L-FMAU | Clevudine |
C0001259 | A chromopeptide antineoplastic antibiotic isolated from the bacterial genus Streptomyces. Actinomycin antibiotics inhibit DNA replication and RNA and protein synthesis by various mechanisms such as intercalating into the minor groove of DNA and interfering with the function of topoisomerase II. | Actinomycines|Actinomycins|actinomycin|Actinomycin|Actinomycin Antineoplastic Antibiotic | Actinomycin |
C0011220 | A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus. | Hepatitis D Viruses|Delta Agent|hepatitis D virus|delta agent|HDV|Hepatitis Delta Virus|delta hepatitis virus|hepatitis delta virus HDV|Hepatitis D virus|HEPATITIS D VIRUS|Delta hepatitis viral agent|HEPATITIS, DELTA VIRUS|Hepatitis delta virus|Delta Viruses, Hepatitis|Hepatitis D Virus|Delta Virus|Hepatitis D virus (organism)|hepatitis d virus|Hepatitis Delta Viruses|HDV - Hepatitis D virus|Delta Agents|Delta Virus, Hepatitis|Delta agent|hepatitis delta virus|Delta Viruses | Hepatitis Delta Virus |
C0024662 | The type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate. | mmtv|mouse mammary tumor virus, MMTV|milk agent|mouse mammary tumor virus MMTV|mammary cancer virus|mouse mammary tumor virus MTV|mouse breast tumor virus|Mouse mammary tumor virus|Bittner Virus|Mammary Cancer Virus|murine mammary tumor provirus MMTV|Mouse Mammary Tumor Virus|mouse mammary tumor virus (MMTV)|Mouse mammary tumor virus (organism)|mouse mammary tumor virus MMT|Mouse mammary tumour virus|Mammary Tumor Viruses, Mouse|Bittner mammary tumor virus|mouse mammary tumor virus|Mammary Tumor Virus, Mouse|MMTV|Bittner virus | Mouse mammary tumor virus |
C0221284 | null | Leptocyte (cell)|target cell|Target cell|Codocyte|TARGET CELLS|Target cells|Bell-shaped erythrocyte (in vivo)|Target Cell|codocyte|Target cell (cell)|cells target|leptocyte|target cells|Leptocyte | Leptocyte |
C0026398 | A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and newborn hamsters. It is apparently transmitted to embryos in utero and to newborns through mother's milk. | Moloney Murine Leukemia Virus M-MuLV|Leukemia Virus, Moloney|Moloney murine leukemia virus|MURINE LEUKEMIA VIRUS SUBTYPE MOLONEY|Virus, Moloney Leukemia|Rat Moloney Murine Leukemia Virus MoMuLV|Moloney Leukemia Virus|MLV|MoMuLV|Moloney Virus|M-MuLV|Moloney Murine Leukemia Virus|Moloney leukemia virus | Moloney Leukemia Virus |
C0033629 | Procedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes. | Proteins, Genetic Engineering|Engineering, Protein|Genetic Engineering, Protein|Protein Genetic Engineering|engineering protein|Engineering, Protein Genetic|Protein engineering|Genetic Engineering of Proteins|protein engineering | Protein Engineering |
C0024075 | Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. | luciferase|Luciferase|Immunologic, Luciferase|Luciferases | Luciferases |
C0948192 | null | primary infection|infections primary|infection primary | primary infection nos |
C0324814 | null | Mandrill|Mandrillus sphinx (organism)|Mandrill baboon|Mandrillus sphinx|Papio sphinx|mandrill|Mandrills | Mandrillus sphinx |
C0242656 | The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. | disease course|Disease Progression|Course of illness|progression|Progression, Disease|Progression of disease|disease progression|Progression|courses disease|Progressions, Disease|course illness|Disease Progressions|course of illness|Course of illness (attribute) | Disease Progression |
C0228339 | A motor nucleus that is part of the ventral tier of the lateral thalamic nuclei group, which projects to the cerebral motor cortex. | Thalami, Nucleus Ventrolateralis|Nucleus Ventrolateralis Thalamus|Ventral lateral complex of thalamus|Structure of ventral lateral nucleus of thalamus|Lateral ventral nucleus of thalamus|Intermedius, Nucleus Ventralis|Ventral Lateral Nucleus|Ventrolateral nucleus of thalamus|Thalamic Nucleus, Ventrolateral|Nucleus Ventralis Intermedius|Nucleus, Ventrolateral Thalamic|Nucleus ventralis thalami lateralis|Nucleus ventralis lateralis thalami|Ventrolateral Nucleus of the Thalamus|Laterali, Nucleus Ventralis|Ventral lateral nucleus of thalamus|Thalamus, Ventrolateral|Ventralis Intermedius, Nucleus|Ventrolateral thalamic nucleus|Ventrolateralis Thalamus, Nucleus|Ventrolateral Thalamus|Ventral lateral nucleus|Nucleus, Ventral Lateral|Nucleus ventralis lateralis|Nucleus Ventralis Laterali|Ventralis Laterali, Nucleus|Ventrolateral Thalamic Nucleus|Lateralis, Nucleus Ventralis|Nucleus Ventralis Lateralis|Ventralis Lateralis, Nucleus|Ventral Lateral Thalamic Nucleus|Structure of ventral lateral nucleus of thalamus (body structure)|Nucleus Ventrolateralis Thalami|Ventral lateral thalamic nuclei|Thalamus, Nucleus Ventrolateralis|VL|Nuclei ventrales laterales thalami|Thalamus, lateral ventral nucleus|Ventrolateralis Thalami, Nucleus|Ventral Lateral Thalamic Nuclei | Ventral Lateral Thalamic Nucleus |
C0963312 | null | cancer-testis antigen 2 protein, human|ESO2 protein, human|LAGE-1 antigen, human|CTL-recognized antigen on melanoma protein, human | CTAG2 protein, human |
C0963312 | null | cancer-testis antigen 2 protein, human|ESO2 protein, human|LAGE-1 antigen, human|CTL-recognized antigen on melanoma protein, human | CTAG2 protein, human |
C0064691 | null | null | laurylpropylenediamine |
C0064691 | null | null | laurylpropylenediamine |
C0044602 | A phosphatidylinositol 3-kinase that catalyzes the conversion of 1-phosphatidylinositol into 1-phosphatidylinositol 3-phosphate. | EC 2.7.1.153|1-phosphatidylinositol 3-kinase|3 pi kinase|pi 3 kinase|Phosphatidylinositol 3 Kinase|1 Phosphatidylinositol 3 Kinase|Phosphoinositide 3 Kinase|Phosphatidylinositide 3-Kinase|PI3 kinase|Phosphatidylinositol-3-Kinase|pi3-kinase|phosphatidylinositol 3-kinase|1-Phosphatidylinositol 3-Kinase|1-phosphatidylinositol 3-kinase (substance)|Phosphatidylinositol-4,5-Bisphosphate 3-Kinase|Phosphatidylinositol 3-Kinase|PI3 Kinase|Phosphatidylinositol 3-kinase|PI3k|PI 3 Kinase|pi3 kinase|Kinase, Phosphoinositide 3|PI3K|3 kinases pi|PI3-Kinase|Type I Phosphatidylinositol Kinase|phosphatidylinositol-3 kinase|Type III Phosphoinositide 3-Kinase|PI3-kinase|phosphatidylinositol 3 kinase | 1-Phosphatidylinositol 3-Kinase |
C0015767 | A species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas (see also SARCOMA VIRUSES, FELINE). | feline leukemia virus|Feline leukemia virus|Leukemia Virus, Cat|felv|Feline leukemia virus (organism)|Feline Leukemia Viruses|Feline leukemia provirus|Leukemia Viruses, Cat|FeLV|feline leukemia virus FeLV|Feline Lymphoma Viruses|Feline Leukemia Virus|Lymphoma Viruses, Feline|Feline leukaemia virus|cat leukemia virus|Leukemia Viruses, Feline|Feline Lymphoma Virus|feline leukemia virus (FeLV)|Cat Leukemia Virus|Lymphoma Virus, Feline|Cat Leukemia Viruses|Leukemia Virus, Feline | Feline leukemia virus |
C1335144 | A gene from one species which corresponds to a gene in another species that is related via a common ancestral species (a homologous gene), but which has evolved to become different from the gene of the other species. | Ortholog | Orthologous Gene |
C0079337 | A species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma (FIP-P), Oma (FIP-O) and Puma lentivirus (PLV). There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells. | FTLV|fiv|Feline T Lymphotropic Lentivirus|Feline Immunodeficiency Virus|feline immunodeficiency virus FIV|Feline immunodeficiency virus (organism)|Feline immunodeficiency virus|FIV|Feline T-lymphotropic virus|Feline AIDS virus|Feline T-Lymphotropic Lentivirus|T-Lymphotropic Lentivirus, Feline|Lentivirus, Feline T-Lymphotropic|Feline T-Lymphotropic Virus|feline immunodeficiency virus (FIV)|Immunodeficiency Virus, Feline|Feline T Lymphotropic Virus|T-Lymphotropic Virus, Feline|feline immunodeficiency virus|Feline Immunodeficiency Viruses | Feline Immunodeficiency Virus |
C0949639 | The first nucleotide of a transcribed DNA sequence where RNA polymerase (DNA-DIRECTED RNA POLYMERASE) begins synthesizing the RNA transcript. | Initiation Sites, Transcription|Start Sites, Transcription|Transcription Start Sites|Sites, Transcription Start|Start Site, Transcription|Transcription Start Site|Sites, Transcription Initiation|Initiation Site, Transcription|Site, Transcription Initiation|Transcription Initiation Sites|Site, Transcription Start | Transcription Initiation Site |
C0021333 | The type species of the genus ARTERIVIRUS and the etiologic agent of an important equine respiratory disease causing abortion, pneumonia, or other infections. | Equine Infectious Arteritis Virus|Infectious Arteritis Virus, Equine|Equine arteritis virus|Equine arteritis virus (organism)|Arteritis Viruses, Equine|Arteritis Virus, Equine|Infectious Arteritis Virus of Horses|Equine Arteritis Viruses|Equine Arteritis Virus|equine arteritis virus | Equine arteritis virus |
C0206485 | A genus of the family ARTERIVIRIDAE, in the order NIDOVIRALES. The type species is EQUARTEVIRUS. | Genus Arterivirus|Arterivirus|Arterivirus (organism)|Arteriviruses | Arterivirus |
C0012512 | Peptides composed of two amino acid units. | Dipeptide (substance)|dipeptide|Dipeptide|dipeptides | Dipeptides |
C0042736 | Proteins found in any species of virus. | viral proteins|Viral Gene Products|protein virus|Proteins, Viral|Virus Protein|virus protein|Viral Gene Proteins|Gene Products, Viral|Viral Protein|Viral proteins | Viral Proteins |
C0035369 | Virus diseases caused by the RETROVIRIDAE. | Infection, Retrovirus|Disease caused by Retroviridae (disorder)|Disease caused by Retroviridae|retrovirus infection|Retroviridae disease|infection retroviral|Infection, Retroviridae|infection retrovirus|Retrovirus infections|Retroviridae Infection|DISEASES DUE TO RETROVIRIDAE|Infections, Retrovirus|Retrovirus Infections|Retrovirus Infection|Infections, Retroviridae|Retrovirus infection|retroviral infection|Disease due to Retroviridae|retroviral disease | Retroviridae Infections |
C0021743 | Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). | Type I Interferons|Interferon, Type I|Interferons, Type I|Type I Interferon|Interferons Type I | Interferon Type I |
C0042774 | The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. | replication virus|Replications, Virus|virus multiplication|virus replication|viral replication|Replication, Virus|Virus Replications | Virus Replication |
C0668894 | null | ORF 73, HHV-8|LANA (antigen)|LANA-1 protein, HHV-8|latency-associated nuclear antigen | latency-associated nuclear antigen |
C0001126 | A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS. | Renal tubular acidosis|ACIDOSIS RENAL TUBULAR|acidosis tubular renal|ACIDOSIS, RENAL HYPERCHLOREMIC|Renal tubular acidosis (disorder)|RENAL ACIDOSIS TUBULAR|Accumulation of acid in body due to kidney problem|acidosis renal tubules|Renal Tubular Acidosis|renal tubular acidosis|ACIDOSIS, RENAL, TUBULAR|Acidosis, Renal Tubular|Renal tubular acidosis, NOS|RTA, NOS|rta|tubular renal acidosis|renal tubule acidosis|RTA - Renal tubular acidosis | Renal tubular acidosis |
C0206429 | Clusters of neurons in the somatic peripheral nervous system which contain the cell bodies of sensory nerve axons. Sensory ganglia may also have intrinsic interneurons and non-neuronal supporting cells. | Sensory ganglion|Ganglion sensorium|Ganglia, Sensory|Sensory Ganglia|Ganglion, Sensory|Sensory Ganglion | Ganglia, Sensory |
C0440926 | null | Dartos flap (substance) | Dartos flap |
C0440926 | null | Dartos flap (substance) | Dartos flap |
C0243650 | An enzyme involved in the MEVALONATE pathway, it catalyses the synthesis of farnesyl diphosphate from isopentenyl diphosphate and dimethylallyl diphosphate. | Farnesyl-diphosphate synthase|Farnesyl Diphosphate Synthetase|FPP Synthetase|Farnesyl Diphosphate Synthase|Pyrophosphate Synthetase, Farnesyl|Diphosphate Synthase, Farnesyl|Synthetase, Farnesyl Pyrophosphate|Geranyltransferase|Synthetase, Farnesyl Diphosphate|Geranyltranstransferase (substance)|Synthase, Farnesyl Diphosphate|Synthetase, FPP|Diphosphate Synthetase, Farnesyl|Farnesyl Pyrophosphate Synthetase|Geranyltranstransferase | Geranyltranstransferase |
C0242610 | A codon that directs initiation of protein translation (TRANSLATION, GENETIC) by stimulating the binding of initiator tRNA (RNA, TRANSFER, MET). In prokaryotes, the codons AUG or GUG can act as initiators while in eukaryotes, AUG is the only initiator codon. | Codon, Start|Initiator Codon|Codon, Initiation|Initiator Codons|Start Codons|Start Codon|Initiation Codon|Codons, Initiator|Initiation Codons|Codons, Start|Codons, Initiation | Codon, Initiator |
C0003261 | The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. | Antibody Response|Antibody Responses|Antibody Formation|antibody response|antibodies response|antibody formation|Production, Antibody|Responses, Antibody|immunoglobulin biosynthesis|antibody production|Response, Antibody|immunoglobulin production|Antibody Production|antibodies production|Formation, Antibody | Antibody Formation |
C0004179 | Experimental devices used in inhalation studies in which a person or animal is either partially or completely immersed in a chemically controlled atmosphere. | Atmosphere Exposure Chamber|Exposure Chamber, Atmosphere|Chambers, Atmosphere Exposure|Chamber, Atmosphere Exposure|Exposure Chambers, Atmosphere | Atmosphere Exposure Chambers |
C0011602 | A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed) | dermatan sulphate|Chondroitin Sulfate B|Chondroitin sulphate B|chondroitin sulfate B|Dermatan, 4-(hydrogen sulfate)|Sulfate B, Chondroitin|Dermatan sulfate (substance)|Dermatan|Chondroitin sulfate B|beta heparin|Dermatan sulfate|beta-Heparin|beta Heparin|dermatan sulfate|Dermatan sulphate|Sulfate, Dermatan | Dermatan Sulfate |
C0005670 | A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances. | BK Polyomavirus|bk polyomavirus|Polyomavirus Type BK|Polyomavirus BK|Polyomavirus hominis 1|Human polyomavirus type BK|BK Virus|polyomavirus bk|Human polyomavirus 1|BK POLYOMAVIRUS|BK virus BKV|Papovavirus BKV|Human polyomavirus BK|Human polyomavirus BKV|bk virus|Polyomavirus BK, Human|Human polyomavirus (type BK)|BKV|BK polyomavirus|human polyomavirus type BK BKV|BK virus|polyomavirus BK|BK polyomavirus (organism)|Polyomavirus, BK|Human Polyomavirus BK | BK Virus |
C0003827 | The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders. | art therapies|art therapy|Art therapy|arts therapy|Arts-based approach|Art therapy (regime/therapy)|Therapy, Art|Therapies, Art|Arts-based therapy|Art Therapies|arts therapies|Art Therapy | Art Therapy |
C0019168 | Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. | hbs ag|Hepatitis B virus surface antigen-containing product|Hepatitis associated antigen|hepatitis associated antigen|Hb s Ag|Antigen, Australia|Australia antigen|hepatitis surface antigen|Hepatitis B virus surface antigen|Hepatitis B Virus Surface Antigen|Surface antigen of Hepatitis B virus (substance)|Hepatitis B Surface Antigens|HEPATITIS B SURFACE ANTIGEN|hepatitis b surface antigen|Australian antigen|hbsag|HBs Ag|Product containing surface antigen of Hepatitis B virus (medicinal product)|australian antigen|AUSTRALIA ANTIGEN|antigen australia|Hepatitis surface antigen|HBsAg (hepatitis B surface antigen)|Hbs Ag|australia antigen|Hepatitis B Surface Antigen|HBsAg|hepatitis B surface antigen|HbsAg|Surface antigen of Hepatitis B virus|hb s ag|Hepatitis B surface antigen|Hepatitis B Virus HBsAg Surface Protein Antigen|HAA (hepatitis associated antigen)|HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN|Australia Antigen|Hepatitis B virus surface Ag|hb ag|HBSAG | Hepatitis B Surface Antigens |
C0019168 | Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. | hbs ag|Hepatitis B virus surface antigen-containing product|Hepatitis associated antigen|hepatitis associated antigen|Hb s Ag|Antigen, Australia|Australia antigen|hepatitis surface antigen|Hepatitis B virus surface antigen|Hepatitis B Virus Surface Antigen|Surface antigen of Hepatitis B virus (substance)|Hepatitis B Surface Antigens|HEPATITIS B SURFACE ANTIGEN|hepatitis b surface antigen|Australian antigen|hbsag|HBs Ag|Product containing surface antigen of Hepatitis B virus (medicinal product)|australian antigen|AUSTRALIA ANTIGEN|antigen australia|Hepatitis surface antigen|HBsAg (hepatitis B surface antigen)|Hbs Ag|australia antigen|Hepatitis B Surface Antigen|HBsAg|hepatitis B surface antigen|HbsAg|Surface antigen of Hepatitis B virus|hb s ag|Hepatitis B surface antigen|Hepatitis B Virus HBsAg Surface Protein Antigen|HAA (hepatitis associated antigen)|HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN|Australia Antigen|Hepatitis B virus surface Ag|hb ag|HBSAG | Hepatitis B Surface Antigens |
C1333196 | Cytokines are soluble glycoproteins released by cells of the immune system, which act nonenzymatically through specific receptors to regulate immune responses. Cytokines resemble hormones in that they act at low concentrations and bind with high affinity to a specific receptor. | null | Cytokine Gene |
C0032556 | A genus of potentially oncogenic viruses of the family POLYOMAVIRIDAE. These viruses are normally present in their natural hosts as latent infections. The virus is oncogenic in hosts different from the species of origin. | Viruses, Polyoma|Virus, Polyoma|POLYOMAVIRUS|Genus Polyomavirus|Polyoma|Polyomavirus, NOS|Polyoma virus|polyoma virus|Polyoma Viruses|Papovavirus, subgroup B|Polyomavirus|Polyomaviruses|Polyomavirus sp.|polyomavirus|Genus Polyomavirus (organism)|Polyoma Virus | Polyomavirus |
C0275518 | null | Acute infectious disease (disorder)|acute infection|Acute infection|Acute infectious disease|acute infections|infection acute | Acute infectious disease |
C0312737 | null | Immunologic cell (cell)|memory cell|Memory cells|memory cells|Memory cell, NOS|cell memory|Immunocyte|IMMUNOLOGIC CELLS|Immunocyte, NOS|immunocyte|Memory cell|Immunologic cell, NOS | Immunologic cell |
C0344441 | A diagnostic test used to examine and define microscopic tissue structure, composition, or etiology. The test results are often used by a clinician to diagnose disease or disordered function. | Histology test|Histologic Test|Histology (as purpose of biopsy)|Histologic test (procedure)|Histologic test|histologic test | Histology Procedure |
C0001490 | Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-G. | Adenovirus, Human|Human adenovirus sp.|APC Viruses|Human adenovirus (organism)|Human Adenovirus|Human adenovirus|Human adenovirus, NOS|APC Virus|Human Adenoviruses | Adenoviruses, Human |
C0035679 | A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. | DNA Dependent RNA Polymerase II|Ribonucleic acid polymerase II|Ribonucleic acid polymerase II (substance)|RNA Polymerase B|RNA Polymerase II|POLR2|RNA polymerase II|DNA-Dependent RNA Polymerase II|RNA Pol II|Pol II|RNAP II | RNA Polymerase II |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.